DAWES KAREN A 4
4 · REPLIGEN CORP · Filed Aug 30, 2023
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
DAWES KAREN A
Director
Transactions
- Exercise/Conversion
Common Stock
2023-08-29$18.12/sh+7,392$133,943→ 84,591 total - Sale
Common Stock
2023-08-29$171.38/sh−850$145,673→ 83,741 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-08-29+7,392→ 0 totalExercise: $18.12Exp: 2024-05-15→ Common Stock (7,392 underlying)
Footnotes (2)
- [F1]$171.38 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.37 to $171.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]This option is fully vested and exercisable.